$2.5T
Total marketcap
$192.14B
Total volume
BTC 50.02%     ETH 15.78%
Dominance

Krystal Biotech KRYS Stock

168.53 USD {{ price }} -2.572550% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
4.77B USD
LOW - HIGH [24H]
165.56 - 172.32 USD
VOLUME [24H]
387.45K USD
{{ volume }}
P/E Ratio
432.12
Earnings per share
0.39 USD

Krystal Biotech Price Chart

Krystal Biotech KRYS Financial and Trading Overview

Krystal Biotech stock price 168.53 USD
Previous Close 129.38 USD
Open 129.05 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 124.19 - 129.05 USD
52 Week Range 51.68 - 131.8 USD
Volume 348.46K USD
Avg. Volume 282.03K USD
Market Cap 3.22B USD
Beta (5Y Monthly) 0.833802
PE Ratio (TTM) N/A
EPS (TTM) 0.39 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 135.88 USD

KRYS Valuation Measures

Enterprise Value 2.88B USD
Trailing P/E N/A
Forward P/E -62.984848
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 6.571293
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -22.488

Trading Information

Krystal Biotech Stock Price History

Beta (5Y Monthly) 0.833802
52-Week Change 124.70%
S&P500 52-Week Change 20.43%
52 Week High 131.8 USD
52 Week Low 51.68 USD
50-Day Moving Average 99.68 USD
200-Day Moving Average 81.46 USD

KRYS Share Statistics

Avg. Volume (3 month) 282.03K USD
Avg. Daily Volume (10-Days) 312.89K USD
Shares Outstanding 25.8M
Float 18.94M
Short Ratio 3.17
% Held by Insiders 15.02%
% Held by Institutions 83.10%
Shares Short 1.19M
Short % of Float 5.45%
Short % of Shares Outstanding 4.62%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -14.32%
Return on Equity (ttm) -26.068%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -127884000 USD
Net Income Avi to Common (ttm) -135307008 USD
Diluted EPS (ttm) -5.08
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 350.39M USD
Total Cash Per Share (mrq) 13.58 USD
Total Debt (mrq) 8.76M USD
Total Debt/Equity (mrq) 1.79 USD
Current Ratio (mrq) 10.133
Book Value Per Share (mrq) 18.978

Cash Flow Statement

Operating Cash Flow (ttm) -111232000 USD
Levered Free Cash Flow (ttm) -109634128 USD

Profile of Krystal Biotech

Country United States
State PA
City Pittsburgh
Address 2100 Wharton Street
ZIP 15203
Phone 412 586 5830
Website https://www.krystalbio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 210

Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the United States. It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis. The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Q&A For Krystal Biotech Stock

What is a current KRYS stock price?

Krystal Biotech KRYS stock price today per share is 168.53 USD.

How to purchase Krystal Biotech stock?

You can buy KRYS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Krystal Biotech?

The stock symbol or ticker of Krystal Biotech is KRYS.

Which industry does the Krystal Biotech company belong to?

The Krystal Biotech industry is Biotechnology.

How many shares does Krystal Biotech have in circulation?

The max supply of Krystal Biotech shares is 28.29M.

What is Krystal Biotech Price to Earnings Ratio (PE Ratio)?

Krystal Biotech PE Ratio is 432.12820000 now.

What was Krystal Biotech earnings per share over the trailing 12 months (TTM)?

Krystal Biotech EPS is 0.39 USD over the trailing 12 months.

Which sector does the Krystal Biotech company belong to?

The Krystal Biotech sector is Healthcare.

Krystal Biotech KRYS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Global Market Composite NQGM 2185.85 USD
-0.31
2177.48 USD 2204.21 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD